| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
202,919 |
155,664 |
$25.50M |
| H2020 |
Therapeutic behavioral services, per diem |
35,038 |
18,532 |
$2.92M |
| 99051 |
|
11,643 |
10,063 |
$81K |
| D0999 |
Unspecified diagnostic procedure, by report |
1,834 |
892 |
$39K |
| 3074F |
|
55,294 |
44,818 |
$8K |
| 3078F |
|
47,192 |
38,566 |
$7K |
| 3079F |
|
29,212 |
24,896 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
25,683 |
20,575 |
$4K |
| 3077F |
|
15,168 |
13,014 |
$3K |
| 3075F |
|
12,960 |
11,438 |
$3K |
| 0001A |
|
502 |
230 |
$2K |
| 0002A |
|
454 |
211 |
$2K |
| 3080F |
|
6,990 |
6,068 |
$1K |
| 0011A |
|
1,077 |
543 |
$1K |
| 0012A |
|
928 |
470 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
138,590 |
107,677 |
$982.53 |
| 0064A |
|
293 |
96 |
$751.13 |
| 96127 |
|
8,019 |
6,594 |
$750.75 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,846 |
23,281 |
$500.00 |
| 0031A |
|
213 |
113 |
$148.98 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
19,819 |
8,167 |
$110.00 |
| 80305 |
|
11,796 |
8,100 |
$90.00 |
| 3044F |
|
294 |
269 |
$70.00 |
| 99050 |
|
21 |
20 |
$66.90 |
| 0004A |
|
58 |
31 |
$50.00 |
| 96160 |
|
103,552 |
82,000 |
$45.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,716 |
2,935 |
$42.23 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,332 |
2,045 |
$41.38 |
| 90832 |
Psychotherapy, 30 minutes with patient |
9,151 |
5,860 |
$30.00 |
| 99177 |
|
634 |
562 |
$10.11 |
| 81003 |
|
19,934 |
15,063 |
$0.00 |
| D1110 |
Prophylaxis - adult |
404 |
174 |
$0.00 |
| 1160F |
|
23,850 |
18,426 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,652 |
9,019 |
$0.00 |
| 99173 |
|
9,658 |
7,408 |
$0.00 |
| 1159F |
|
22,456 |
17,192 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,576 |
1,863 |
$0.00 |
| 82947 |
|
10,957 |
7,703 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
6,554 |
5,268 |
$0.00 |
| D0330 |
Panoramic radiographic image |
294 |
137 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,257 |
6,342 |
$0.00 |
| 81025 |
|
1,967 |
1,687 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,013 |
2,708 |
$0.00 |
| 90633 |
|
263 |
242 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
666 |
460 |
$0.00 |
| 90670 |
|
649 |
612 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
388 |
338 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,025 |
906 |
$0.00 |
| 90734 |
|
146 |
108 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,323 |
1,184 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
198 |
161 |
$0.00 |
| G8404 |
Lower extremity neurological exam performed and documented |
225 |
197 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
1,405 |
1,068 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
56 |
37 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
904 |
805 |
$0.00 |
| 90648 |
|
109 |
108 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
126 |
111 |
$0.00 |
| 99188 |
|
727 |
559 |
$0.00 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
418 |
386 |
$0.00 |
| 90672 |
|
511 |
391 |
$0.00 |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
182 |
182 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
44 |
39 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
68 |
54 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
200 |
170 |
$0.00 |
| G8477 |
Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg |
113 |
106 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
288 |
260 |
$0.00 |
| 91300 |
|
1,313 |
519 |
$0.00 |
| 90836 |
|
64 |
30 |
$0.00 |
| 1158F |
|
50 |
42 |
$0.00 |
| 90461 |
|
206 |
166 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
56 |
37 |
$0.00 |
| 99401 |
|
28 |
28 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
340 |
278 |
$0.00 |
| 90756 |
|
102 |
89 |
$0.00 |
| 90700 |
|
14 |
13 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
339 |
244 |
$0.00 |
| D0274 |
Bitewings - four radiographic images |
158 |
59 |
$0.00 |
| G8476 |
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg |
107 |
100 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
65 |
28 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
60 |
53 |
$0.00 |
| 3725F |
|
16 |
13 |
$0.00 |
| 81002 |
|
19 |
18 |
$0.00 |
| 90710 |
|
91 |
91 |
$0.00 |
| 90685 |
|
32 |
25 |
$0.00 |
| G0468 |
Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv |
76 |
51 |
$0.00 |
| 90715 |
|
39 |
32 |
$0.00 |
| 99442 |
|
22 |
15 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$0.00 |
| 90661 |
|
16 |
13 |
$0.00 |
| 2028F |
|
15 |
13 |
$0.00 |
| 99382 |
|
38 |
25 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
2,811 |
1,910 |
$0.00 |
| 1125F |
|
3,860 |
3,067 |
$0.00 |
| 97802 |
|
1,148 |
801 |
$0.00 |
| 92551 |
|
6,486 |
5,741 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
504 |
436 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
11,282 |
5,107 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,974 |
3,967 |
$0.00 |
| D7140 |
Extraction, erupted tooth or exposed root |
237 |
100 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,112 |
2,790 |
$0.00 |
| 85018 |
|
7,181 |
5,473 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,997 |
2,907 |
$0.00 |
| 36416 |
|
1,684 |
1,391 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
1,614 |
1,415 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
952 |
768 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,930 |
2,461 |
$0.00 |
| 82043 |
|
1,728 |
1,374 |
$0.00 |
| 3011F |
|
211 |
193 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,947 |
4,165 |
$0.00 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
5,596 |
2,987 |
$0.00 |
| 1111F |
|
3,967 |
3,282 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
4,689 |
3,204 |
$0.00 |
| 3008F |
|
6,970 |
5,969 |
$0.00 |
| 1126F |
|
4,635 |
3,841 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
7,316 |
4,380 |
$0.00 |
| 94760 |
|
326 |
245 |
$0.00 |
| 0513F |
|
13 |
13 |
$0.00 |
| 99383 |
|
238 |
232 |
$0.00 |
| 96161 |
|
750 |
653 |
$0.00 |
| 90674 |
|
158 |
147 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
224 |
181 |
$0.00 |
| 91306 |
|
307 |
102 |
$0.00 |
| 90688 |
|
73 |
60 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
98 |
32 |
$0.00 |
| 00000 |
|
224 |
168 |
$0.00 |
| 90686 |
|
1,265 |
1,116 |
$0.00 |
| 99406 |
|
722 |
452 |
$0.00 |
| 00111 |
|
15 |
15 |
$0.00 |
| 91301 |
|
1,989 |
986 |
$0.00 |
| 3061F |
|
213 |
198 |
$0.00 |
| 87807 |
|
556 |
485 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
634 |
242 |
$0.00 |
| 90680 |
|
89 |
85 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
116 |
103 |
$0.00 |
| 99402 |
|
94 |
86 |
$0.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
84 |
53 |
$0.00 |
| 99386 |
|
46 |
45 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
46 |
38 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
456 |
368 |
$0.00 |
| 82270 |
|
27 |
25 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
190 |
146 |
$0.00 |
| 86308 |
|
687 |
581 |
$0.00 |
| 99000 |
|
332 |
286 |
$0.00 |
| 90723 |
|
28 |
26 |
$0.00 |
| 99385 |
|
99 |
95 |
$0.00 |
| 90697 |
|
43 |
40 |
$0.00 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
100 |
74 |
$0.00 |
| 99381 |
|
47 |
39 |
$0.00 |
| 2000F |
|
13 |
13 |
$0.00 |
| 90651 |
|
37 |
28 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
32 |
27 |
$0.00 |
| 99384 |
|
53 |
48 |
$0.00 |
| 1170F |
|
50 |
42 |
$0.00 |
| D0140 |
Limited oral evaluation - problem focused |
13 |
13 |
$0.00 |
| 90698 |
|
44 |
44 |
$0.00 |
| 91303 |
|
224 |
118 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
12 |
12 |
$0.00 |
| 90647 |
|
13 |
12 |
$0.00 |